Drug Discovery Phases: From Discovery to Candidate Selection and Beyond

We provide an integrated drug discovery service aimed at addressing our industry challenges of all drug discovery phases. Applying expertise in synthetic and medicinal chemistry, biology, DMPK and program management, we collaborate closely with our global customers, ranging from pharma and biotech to academia, to rapidly advance programs towards key inflection points and milestones by leveraging peer-recognized expertise and an integrated platform from hit identification through to preclinical candidate selection and beyond. 

Supporting Target ID and validation, hit finding, hit-to-lead, lead optimization, preclinical candidates